Fundz

Ocudyne, Inc. reported raising $886,000 in an initial SEC Form D filing, from an offering of $1.49 Million

PRIVATEAug 22, 2017$886.5K of $1.5M raised

Amount Raised

$886,000

$886,000 sold, per SEC Form D (first sale Aug 22, 2017)

Round Type

Seed

Brooklyn ParkHealthcareHealth Care

Who to call at Ocudyne, and when

A new round usually means Ocudyne is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ocudyne raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ocudyne, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ocudyne. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ocudyne

Location

7600 Boone Avenue North, Suite #7

Brooklyn Park, Minnesota, United States

About

OcuDyne is a clinical-stage medical device company developing a novel therapy to treat Age Related Macular Degeneration (AMD), the leading cause of irreversible vision loss in the elderly worldwide. As a world leader in the evaluation of ocular perfusion and how it influences ocular health, OcuDyne’s mission is to develop therapies that improve blood flow to the eye. Impaired blood flow causes disease in organ systems all over the body, and the eye is no exception. Over the past few years, advances in intracranial and arterial imaging have shown that impared ocular perfusion is present in patients suffering from AMD. As a result, AMD is the first indication being pursued by OcuDyne.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ocudyne raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJeff F., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ocudyne's next move

See what Strategic adds

Ocudyne raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.